Breast imaging company Delphinus Medical Technologies has received $12 million in growth capital to commercialise its SoftVue 3D Whole Breast Ultrasound Tomography system, which was designed to complement digital mammography for screening asymptomatic women with dense breast tissue. Trinity Capital, a growth-stage investor in companies and technologies, is responsible for the funding.